These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 9601836
1. [Famotidine in the treatment of gastropathy induced by non-steroidal antirheumatic agents]. Rybár I, Rovenský J, Hyrdel R. Vnitr Lek; 1997 Apr; 43(4):208-10. PubMed ID: 9601836 [Abstract] [Full Text] [Related]
2. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine. Miyake K, Ueki N, Suzuki K, Shinji Y, Kusunoki M, Hiratsuka T, Nishigaki H, Tatsuguchi A, Futagami S, Wada K, Tsukui T, Nakajima A, Yoshino S, Sakamoto C. Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850 [Abstract] [Full Text] [Related]
3. Does famotidine have similar efficacy to misoprostol in the treatment of non-steroidal anti-inflammatory drug-induced gastropathy? Wu CS, Wang SH, Chen PC, Wu VC. Int J Clin Pract; 1998 Oct; 52(7):472-4. PubMed ID: 10622088 [Abstract] [Full Text] [Related]
4. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. Taha AS, McCloskey C, Prasad R, Bezlyak V. Lancet; 2009 Jul 11; 374(9684):119-25. PubMed ID: 19577798 [Abstract] [Full Text] [Related]
5. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors. Lazzaroni M, Bianchi Porro G. Ital J Gastroenterol Hepatol; 1999 Jul 11; 31 Suppl 1():S73-8. PubMed ID: 10379473 [Abstract] [Full Text] [Related]
6. Famotidine to prevent peptic ulcer caused by NSAIDs. Singh G, Fries JF. N Engl J Med; 1996 Oct 24; 335(17):1322; author reply 1322-3. PubMed ID: 8992334 [No Abstract] [Full Text] [Related]
7. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy. Yeomans ND. Ital J Gastroenterol Hepatol; 1999 Oct 24; 31 Suppl 1():S89-92. PubMed ID: 10379475 [Abstract] [Full Text] [Related]
8. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds. Scarpignato C, Pelosini I. Ital J Gastroenterol Hepatol; 1999 Oct 24; 31 Suppl 1():S63-72. PubMed ID: 10379472 [Abstract] [Full Text] [Related]
9. [Influence of smoking on healing in patients with NSAID-induced peptic ulcer]. Dallera F, Gendarini A, Labadini A, Costa P, Iezzi BG. Minerva Med; 1990 Oct 24; 81(1-2):67-74. PubMed ID: 2314618 [Abstract] [Full Text] [Related]
10. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Pilotto A, Franceschi M, Leandro G, Paris F, Cascavilla L, Longo MG, Niro V, Andriulli A, Scarcelli C, Di Mario F. Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1091-7. PubMed ID: 15569111 [Abstract] [Full Text] [Related]
11. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury. Agrawal NM, Dajani EZ. Int J Clin Pharmacol Res; 1989 Nov 15; 9(6):347-57. PubMed ID: 2576801 [Abstract] [Full Text] [Related]
12. Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis. Hamamoto N, Hashimoto T, Adachi K, Hirakawa K, Ishihara S, Inoue H, Taniura H, Niigaki M, Sato S, Kushiyama Y, Suetsugu H, Miyake T, Kinoshita Y. J Gastroenterol Hepatol; 2005 Feb 15; 20(2):281-6. PubMed ID: 15683433 [Abstract] [Full Text] [Related]
13. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy. Scheiman JM. Am J Manag Care; 2001 Feb 15; 7(1 Suppl):S10-4. PubMed ID: 11225347 [Abstract] [Full Text] [Related]
14. Famotidine to prevent peptic ulcer caused by NSAIDs. Graham DY. N Engl J Med; 1996 Oct 24; 335(17):1322; author reply 1322-3. PubMed ID: 8992333 [No Abstract] [Full Text] [Related]
15. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol. Koch M. Ital J Gastroenterol Hepatol; 1999 Oct 24; 31 Suppl 1():S54-62. PubMed ID: 10379471 [Abstract] [Full Text] [Related]
16. [Modern approach to the prevention and treatment of NSAID-gastropathy]. Drozdov VN, Kim VA, Lazebnik LB. Eksp Klin Gastroenterol; 2011 Oct 24; (2):106-10. PubMed ID: 21560649 [Abstract] [Full Text] [Related]
17. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma. Tsibouris P, Hendrickse MT, Isaacs PE. Aliment Pharmacol Ther; 2004 Sep 15; 20(6):645-55. PubMed ID: 15352913 [Abstract] [Full Text] [Related]
18. [Effectiveness of lecedil (famotidine) in the therapy of patients with peptic ulcer]. Grebenev AL, Sheptulin AA, Smakov GM, Kornienko AA, Trukhmanov AS. Klin Med (Mosk); 1993 Sep 15; 71(6):30-2. PubMed ID: 8145499 [Abstract] [Full Text] [Related]
19. [Treatment of non-steroidal anti-inflammatory drug-induced damage to gastric mucosa using ranitidine. Comparison of the effectiveness of 2 dosages]. Müller P, Dammann HG, Marinis E, Weise D, Simon B. Fortschr Med; 1989 Oct 30; 107(31):667-70. PubMed ID: 2687142 [Abstract] [Full Text] [Related]
20. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs. Nakashima S, Arai S, Mizuno Y, Yoshino K, Ando S, Nakamura Y, Sugawara K, Koike M, Saito E, Naito M, Nakao M, Ito H, Hamaoka K, Rai F, Asakura Y, Akamatu M, Fujimori K, Inao M, Imai Y, Ota S, Fujiwara K, Shiibashi M. Aliment Pharmacol Ther; 2005 Jun 30; 21 Suppl 2():60-6. PubMed ID: 15943849 [Abstract] [Full Text] [Related] Page: [Next] [New Search]